Photocure ASA: Presentation of the first quarter 2017 results and the results from the Blue Light Flexible Cystoscopy with He...

Photocure will present its first quarter report on Tuesday 23 May 2017 at Hotel Continental, Oslo, Norway.

Additionally, Dr. Daneshmand will present the new phase 3 study results with Blue Light Flexible Cystoscopy (BLFC^TM) with Hexvix^®/Cysview^® which recently was presented at the 2017 American Urological Association (AUA) annual meeting.

• 08:00 - 08:35 Q1 presentation by Kjetil Hestdal, President and CEO, and Erik Dahl, CFO.
  The presentation will be held in Norwegian.
• 08:35 - 08:40 Break
• 08:40 - 09:00 Dr. Sia Daneshmand, MD, Associate Professor of Urology (Clinical Scholar); Director of Urologic Oncology, Director of Clinical Research and Urologic Oncology Fellowship Director at the University of Southern California, Los Angeles, USA.
  The presentation will be held in English.

The presentation will be publicly available at www.photocure.com. It will be possible to follow the presentation through http://webtv.hegnar.no/presentation.php?webcastId=52727534.  

A light snack will be served from 07:30 (CET). The presentation is scheduled to conclude at 09:00 (CET).

Photocure will additionally host an audio webcast and conference call (http://webtv.hegnar.no/presentation.php?webcastId=52727745) the same day in English at 17:00 CET / 16:00 GMT / 11:00 EST.
Please join the event conference 5-10 minutes prior to the start time using the number and confirmation code below:

• NORWAY:       [phone]
• UK:                  [phone]
• USA:                [phone]

 Confirmation code: 1958114
It is possible to listen to a replay of the conference call on the following numbers:

• NORWAY         [phone]
• UK                   [phone]
• USA                 [phone]

 Confirmation code: 1958114

Please register your attendance to the breakfast presentation at Photocure by Monday 22 May.
Contact person: Grete Faye-Schjøll (e-mail: [e-mail] / phone [phone] / fax [phone]).

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Photocure ASA via Globenewswire